SACRAMENTO — California’s stem cell agency will receive an infusion of $5.5 billion in new research funding after voters approved Proposition 14. The ballot measure had been leading since the Nov. 3 election before it was called by the Associated Press on Thursday night. The California Institute for Regenerative Medicine, known as CIRM, will receive the additional
Last year, CIRM awarded $5.53 million to Rosa Bacchetta, M.D. at Stanford University to complete the work necessary to conduct a clinical trial for IPEX syndrome. This is a rare disease caused by mutations in the FOXP3 gene, which leaves people with the condition vulnerable to immune system attacks on their organs and tissues. These attacks can be
California voters a few years ago agreed to dive into stem cell research in hopes of finding cures and treatments for 75 diseases and conditions afflicting people. Proposition 14 on the Nov. 3 ballot would keep it going. Previous funding created more than 1,000 medical projects at 70 institutions across the state. Research has saved and improved
In 2008, USC broke ground on an $80 million building dedicated solely to stem cell research and regenerative medicine. The plans called for a monolithic structure clad in black marble and reflective glass, rising five stories and enclosing nearly 90,000 square feet. When it was completed, the university had a stunning new contemporary research space
PALO ALTO, Calif. (KGO) -- If you suffer from joint pain, a new study out of Stanford could hold the possibility of relief, and a time in the future when doctors tune up our joints almost the way we service our cars. "Maybe this is a little bit more like Jiffy Lube, an oil change",
Researchers at the Stanford University School of Medicine have discovered a way to regenerate, in mice and human tissue, the cushion of cartilage found in joints. Loss of this slippery and shock-absorbing tissue layer, called articular cartilage, is responsible for many cases of joint pain and arthritis, which afflicts more than 55 million Americans. Nearly 1 in
Human induced pluripotent stem cell-derived cardiomyocytes (heart cells) shown in green and blue, are infected by the novel coronavirus SARS-CoV-2 (red). Image Courtesy of UCLA Broad Stem Cell Center There is still a lot that we don’t understand about SARS-CoV-2 (COVID-19), the new coronavirus that has caused a worldwide pandemic. Some patients that contract the
Today the governing Board of the California Institute for Regenerative Medicine (CIRM) awarded $750,000 to Dr. Xiaokui Zhang at Celularity to conduct a clinical trial for the treatment of COVID-19. This brings the total number of CIRM clinical trials to 64, including three targeting the coronavirus. This trial will use blood stem cells obtained from
SACRAMENTO — After a last-ditch push for signatures, supporters of a $5.5 billion bond that would keep California’s stem cell research institute in business have qualified their measure for the November ballot. The measure asks voters to re-fund the California Institute for Regenerative Medicine, the state’s stem cell agency, by allowing it to issue bonds for research, training
